Coenzyme Q10 quantification in muscle, fibroblasts and cerebrospinal fluid by liquid chromatography/tandem mass spectrometry using a novel deuterated internal standard

Rapid Communications in Mass Spectrometry

Volumn 27, Issue 9, 2013, Pages 924-930

  Duberley, Kate E C ^a   Hargreaves, Iain P ^b   Chaiwatanasirikul, Korn Anong ^c   Heales, Simon J R ^b,c,d   Land, John M ^b   Rahman, Shamima ^b,c,d   Mills, Kevin ^c   Eaton, Simon ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; CEREBROSPINAL FLUID; COENZYMES; DEUTERIUM; FIBROBLASTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MUSCLE; NEURODEGENERATIVE DISEASES;

COEFFICIENTS OF VARIATIONS; COENZYME Q; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; INTERNAL STANDARDS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; MITOCHONDRIAL DISORDERS; PARA-BENZOQUINONE; THERAPEUTIC BENEFITS; UBIQUINONE;

CELL CULTURE;

DEUTERIUM; DRUG DERIVATIVE; UBIDECARENONE; UBIQUINONE;

ADOLESCENT; ADULT; ARTICLE; CELL CULTURE; CEREBROSPINAL FLUID; CHEMISTRY; CHILD; EVALUATION; FEMALE; FIBROBLAST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; LIMIT OF DETECTION; MALE; METHODOLOGY; MIDDLE AGED; OXIDATION REDUCTION REACTION; PRESCHOOL CHILD; SKELETAL MUSCLE; STANDARD; TANDEM MASS SPECTROMETRY;

ADOLESCENT; ADULT; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEUTERIUM; FEMALE; FIBROBLASTS; HUMANS; INFANT; LIMIT OF DETECTION; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OXIDATION-REDUCTION; REFERENCE STANDARDS; TANDEM MASS SPECTROMETRY; UBIQUINONE; YOUNG ADULT;

EID: 84876268304     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.6529     Document Type: Article

References (39)

1. F. Crane, Y. Hatefi, R. Lester, C. Widmer,. Isolation of a quinone from beef heart mitochondria. Biochim. Biophys. Acta 1957, 25, 220.
2. L. Ernster, G. Dallner,. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta 1995, 1271, 195.
3. M. Turunen, J. Olsson, G. Dallner,. Metabolism and function of coenzyme Q. Biochim. Biophys. Acta Biomembranes 2004, 1660, 171.
4. S. Ogasahara, AG Engel, D. Frens, D. Mack,. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc. Natl. Acad. Sci. USA 1989, 86, 2379.
5. J. Mollet, I. Giurgea, D. Schlemmer, et al,. Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J. Clin. Invest. 2007, 117, 765.
6. L.C. Lõpez, M. Schuelke, C.M. Quinzii, et al,. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am. J. Hum. Genet. 2006, 79, 1125.
7. C. Lagier-Tourenne, M. Tazir, L. Lõpez, et al,. ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. J. Hum. Genet. 2008, March, 661.
8. J. Mollet, A. Delahodde, V. Serre, et al,. CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. J. Hum. Genet. 2008, 82, 623.
9. A. Duncan, M. Bitner-Glindzicz, B. Meunier, et al,. A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease. Am. J. Hum. Genet. 2009, 84, 558.
10. S.F. Heeringa, G. Chernin, M. Chaki, et al,. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J. Clin. Invest. 2011, 121, 2013.
11. S. Rahman, C.F. Clarke, M. Hirano,. 176th ENMC International Workshop: Diagnosis and treatment of coenzyme Q(10) deficiency. Neuromuscular Disord. 2012, 22, 76.
12. O. Musumeci, A. Naini, A.E. Slonim, et al,. Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology 2001, 56, 849.
13. C. Lamperti, A. Naini, M. Hirano, D. C. de Vivo, E. Bertini, S. Servidei,. Cerebellar ataxia and coenzyme Q10 deficiency. Neurology 2003, 60, 1206.
14. R. Horvath, B. Czermin, S. Gulati, et al,. Adult-onset cerebellar ataxia due to mutations in CABC1/ADCK3. J. Neurol. Neurosurg. Psych. 2012, 83, 174.
15. A. Tauche, U. Krause-Buchholz, G. Rödel,. Ubiquinone biosynthesis in Saccharomyces cerevisiae: the molecular organization of O-methylase Coq3p depends on Abc1p/Coq8p. FEMS Yeast Res. 2008, 8, 1263.
16. I. Le Ber, O. Dubourg, J. Benoist, et al,. Muscle coenzyme Q10 deficiencies in ataxia with oculomotor apraxia 1. Neurology 2007, 68, 295.
17. C. Quinzii, G. Kattah, A. Naini, et al,. Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology 2005, 64, 539.
18. J.M. Cooper, L.V.P. Korlipara, P.E. Hart, J.L. Bradley, H.V. Schapira,. Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy. Eur. J. Neurol. 2008, 15, 1371.
19. K. Hyland, J. Shoffner, S. J. Heales,. Cerebral folate deficiency. J. Inherit. Metab. Dis. 2010, 33, 563.
20. C. Isobe, T. Abe, Y. Terayama,. Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the CSF of patients with Alzheimer's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process. J. Neurol. 2010, 257, 399.
21. C. Isobe, T. Abe, Y. Terayama,. Increase in the oxidized/total coenzyme Q-10 ratio in the cerebrospinal fluid of Alzheimer's disease patients. Dement. Geriatr. Cogn. Disord. 2009, 28, 449.
22. T. Murata, C. Ohtsuka, Y. Terayama,. Increased mitochondrial oxidative damage and oxidative DNA damage contributes to the neurodegenerative process in sporadic amyotrophic lateral sclerosis. Free Radical Res. 2008, 42, 221.
23. A. Duncan, S. Heales, K. Mills, S. Eaton, J. Land, I. Hargreaves,. Determination of coenzyme Q10 status in blood mononuclear cells, skeletal muscle, and plasma by HPLC with di-propoxy-coenzyme Q10 as an internal standard. Clin. Chem. 2005, 51, 2380.
24. 10 in human plasma. Clin. Chem. 2001, 47, 256.
25. J. Ruiz-Jiménez, F. Priego-Capote, J.M. Mata-Granados, J.M. Quesada, M.D. Luque de Castro,. Determination of the ubiquinol-10 and ubiquinone-10 (coenzyme Q10) in human serum by liquid chromatography tandem mass spectrometry to evaluate the oxidative stress. J. Chromatogr. A 2007, 1175, 242.
26. S. Takamiya, T. Matsui, H. Taka, K. Murayama, M. Matsuda, T. Aoki,. Free-living nematodes Caenorhabditis elegans possess in their mitochondria an additional rhodoquinone, an essential component of the eukaryotic fumarate reductase system. Arch. Biochem. Biophys. 1999, 371, 284.
27. L. Li, D. Pabbisetty, P. Carvalho, M. Avery, B. Avery,. Analysis of CoQ10 in rat serum by ultra-performance liquid chromatography mass spectrometry after oral administration. J. Pharmaceut. Biomed. Anal. 2008, 46, 137.
28. W.H. Schaefer, J.W. Lawrence, A.F. Loughlin, et al,. Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats. Toxicol. Appl. Pharmacol. 2004, 194, 10.
29. K. Teshima, T. Kondo,. Analytical method for ubiquinone-9 and ubiquinone-10 in rat tissues by liquid chromatography/turbo ion spray tandem mass spectrometry with 1-alkylamine as an additive to the mobile phase. Anal. Biochem. 2005, 338, 12.
30. B. Barshop, J. Gangoiti,. Analysis of coenzyme Q in human blood and tissues. Mitochondrion 2007, 7 (Suppl.), S89.
31. G. Hansen, P. Christensen, E. Tüchsen, T. Lund,. Sensitive and selective analysis of coenzyme Q10 in human serum by negative APCI LC-MS. The Analyst 2004, 129, 45.
32. K. Hamamura, Y. Yamagishi, S. Kijima, T. Suzuki, Y. Mori, T. Nakamura,. Synthesis of deuterium-labelled coenzyme Q10. J. Labelled Compd. Rad. 2002, 45, 831.
33. 14C] coenzyme Q10. J. Labelled Compd. Rad. 2002, 45, 823.
34. P.O. Edlund,. Determination of coenzyme Q10, α-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection. J. Chromatography 1988, 425, 87.
35. F.L. Crane, R. Barr,. Determination of ubiquinones. Methods Enzymol. 1971, 18, 137.
36. O. Lowry, N. Rosebrough, A. Farr, R. Randall,. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265.
37. 10 in children and adolescents undergoing doxorubicin therapy. Clin. Chim. Acta 2000, 302, 1.
38. R. Montero, M. Pineda, A. Aracil, et al,. Clinical, biochemical and molecular aspects of cerebellar ataxia and coenzyme Q10 deficiency. Cerebellum 2007, 6, 118.
39. S. Rahman, I. Hargreaves, P. Clayton, S. Heales,. Neonatal presentation of coenzyme Q10 deficiency. J. Pediatrics 2001, 139, 456.